June 24
Ablitech Receives Additional Investment
Investment to help bring Disease-Fighting Versadel to Market Faster
Hattiesburg, Mississippi-based Noetic Technologies Chief Executive Officer Leslie Goff announced today that they have made a cash and strategic services investment into Ablitech, Inc.
“It is critical that we support promising technology companies like Ablitech,” Goff stated. “The process of developing technology, validating the technology, and creating a customer-ready product is extremely challenging. Noetic Technologies is staffed and has the expertise to execute these processes.”
Founded in 2006, Ablitech’s signature product is Versadel, which has the potential to stop cancer and most degenerative diseases through the targeted delivery of genetic material into specific cells.
Ablitech CEO Ken Malone stated, “We are proud and honored that Noetic Technologies has decided to invest financially and intellectually into our company because it will help us bring Versadel to market sooner which could save lives faster.
Malone added, “Versadel has the potential to revolutionize the way we treat diseases, which makes this investment a significant step toward helping those in need.”
About Noetic Technologies:
Founded in 2004, Noetic Technologies has had a vital role in bringing ideas to the marketplace for several high technology companies. With a management team comprised of more than fifty years of experience in market research, product development, process management and marketing strategies, Noetic has the expertise to connect new technologies to the marketplace.
About Ablitech, Inc.:
Ablitech, founded in 2006, is a Hattiesburg, Mississippi-based company that draws from the latest advances in polymer science and medicinal chemistry. Ablitech develops radical technologies for healing the human body. Ablitech's flagship product line, VersadelTM, is a technology that enables gene therapies for the treatment of all forms of cancer and other life threatening diseases. For more information regarding Ablitech, please visit www.ablitech.com.
 |